Transforming growth factor-alpha, epidermal growth factor receptor, and PCNA immunoexpression in uterine leiomyosarcomas and leiomyomas in B6C3F1 mice

被引:8
作者
Moore, AB
He, H
Yoshida, A
Rico, PJ
Haseman, JK
Dixon, D
机构
[1] NIEHS, Res Triangle Pk, NC 27709 USA
[2] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA
关键词
transforming growth factor-alpha; epidermal growth factor receptor; immunoexpression; growth factors; cell proliferation; uterine leiomyoma; leiomyosarcoma; proliferating cell nuclear antigen; PCNA;
D O I
10.1016/S0940-2993(00)80028-7
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The role of growth factors in the development of murine uterine mesenchymal tumors is unknown. In this study, immunohistochemical expression of transforming growth factor alpha (TGF-alpha) and its receptor epidermal growth factor (EGF-R) was assessed in spontaneous uterine leiomyomas and leiomyosarcomas in B6C3F1 mice. Cell proliferation, which has been induced by some growth factors, was evaluated by immunohistochemical detection of an endogenous marker of cell proliferation, proliferating cell nuclear antigen (PCNA). PCNA labeling indices were determined and compared to the intensity and distribution of TGF-alpha staining in sequential sections of control myometrium or tumor tissue. Results showed uterine leiomyosarcomas had positive cytoplasmic staining for TGF-alpha; however, all uterine leiomyomas evaluated were negative. Positive EGF-R staining was also observed in the uterine leiomyosarcomas, but not in the leiomyomas. EGFR immunoexpression was detected primarily within the cytoplasm of the leiomyosarcoma cells, with occasional nuclear immunoreactivity. Immunohistochemical staining for PCNA was more intense and there were increased numbers of positively staining nuclei in the leiomyosarcomas compared to samples of control myometrium or leiomyomas. The mean labeling index for the uterine leiomyosarcomas (7.40%) was significantly (p < 0.01) higher than that of leiomyomas (0.29%) and control uterine myometrium (0.13%). We conclude, that TGF-alpha and its receptor, EGFR, are expressed more intensely in uterine leiomyosarcomas, compared to leiomyomas in B6C3F1 mice. Immunoexpression of TGF-alpha may be an important biomarker of malignancy in uterine smooth muscle tumors in mice. Futhermore, TGF-alpha may play a critical role in increased proliferation of uterine smooth muscle tumor cells as suggested by increased immunolocalization of PCNA in rodent leiomyosarcomas expressing TGF-alpha, although other factors regulating cell replication can not be ruled out.
引用
收藏
页码:195 / 200
页数:6
相关论文
共 34 条
  • [1] AOYAMA H, 1997, J HISTOCHEM CYTOCHEM, V45, P696
  • [2] CYCLIN PCNA IS THE AUXILIARY PROTEIN OF DNA POLYMERASE-DELTA
    BRAVO, R
    FRANK, R
    BLUNDELL, PA
    MACDONALDBRAVO, H
    [J]. NATURE, 1987, 326 (6112) : 515 - 517
  • [3] BUTTRAM VC, 1981, FERTIL STERIL, V36, P433
  • [4] Chaudhury RR., 1981, PHARM ESTROGENS INT, P63
  • [5] PRODUCTION AND AUTOINDUCTION OF TRANSFORMING GROWTH FACTOR-ALPHA IN HUMAN KERATINOCYTES
    COFFEY, RJ
    DERYNCK, R
    WILCOX, JN
    BRINGMAN, TS
    GOUSTIN, AS
    MOSES, HL
    PITTELKOW, MR
    [J]. NATURE, 1987, 328 (6133) : 817 - 820
  • [6] CRUM CP, 1994, PATHOLOGIC BASIS DIS, P1033
  • [7] HUMAN TRANSFORMING GROWTH FACTOR-ALPHA - PRECURSOR STRUCTURE AND EXPRESSION IN ESCHERICHIA-COLI
    DERYNCK, R
    ROBERTS, AB
    WINKLER, ME
    CHEN, EY
    GOEDDEL, DV
    [J]. CELL, 1984, 38 (01) : 287 - 297
  • [8] TRANSFORMING GROWTH FACTOR-ALPHA
    DERYNCK, R
    [J]. CELL, 1988, 54 (05) : 593 - 595
  • [9] ACTIVATION OF GROWTH-FACTOR SECRETION IN TUMORIGENIC STATES OF BREAST-CANCER INDUCED BY 17-BETA-ESTRADIOL OR V-HA-RAS ONCOGENE
    DICKSON, RB
    KASID, A
    HUFF, KK
    BATES, SE
    KNABBE, C
    BRONZERT, D
    GELMANN, EP
    LIPPMAN, ME
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (03) : 837 - 841
  • [10] AN ENHANCEMENT METHOD FOR IMMUNOHISTOCHEMICAL STAINING OF PROLIFERATING CELL NUCLEAR ANTIGEN IN ARCHIVAL RODENT TISSUES
    GREENWELL, A
    FOLEY, JF
    MARONPOT, RR
    [J]. CANCER LETTERS, 1991, 59 (03) : 251 - 256